Mark C. Schiller

Business address
C/O Kezar Life Sciences, Inc., 4000 Shoreline Court, Suite 300, South San Francisco, CA, 94080
Top holdings (ownership)
KZR
Get insider transactions for this reporting owner
Mark C. Schiller has filed 6 SEC EDGAR filings since 17 Jan 2024

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 03 Jul 2025 02 Jul 2025 001-38542
4 Open Document Open Filing 01 Apr 2025 27 Mar 2025 001-38542
4 Open Document Open Filing 05 Mar 2025 04 Mar 2025 001-38542
4 Open Document Open Filing 13 Jan 2025 09 Jan 2025 001-38542
4 Open Document Open Filing 26 Jul 2024 02 Jul 2024 001-38542
3 Open Document Open Filing FORM 3 SUBMISSION 17 Jan 2024 15 Jan 2024 001-38542